FRDB Archives

Freethought & Rationalism Archive

The archives are read only.


Go Back   FRDB Archives > Archives > IIDB ARCHIVE: 200X-2003, PD 2007 > IIDB Philosophical Forums (PRIOR TO JUN-2003)
Welcome, Peter Kirby.
You last visited: Yesterday at 05:55 AM

 
 
Thread Tools Search this Thread
Old 07-01-2003, 06:11 AM   #51
Veteran Member
 
Join Date: Mar 2001
Location: Louisville, KY, USA
Posts: 1,840
Default

Quote:
Koy:
This, naturally caused a flurry of questions, to which she responded that the clinical research on memory retention/loss did not factor in information that was learned or otherwise acquired while on psychoactive drugs; that a pot smoker, for example, might not remember something while off the drug something that was learned while on it and vice versa, but that clinical research had shown (and she didn't cite) that something learned (and she was referring to rote or repetitive information learning, such as study) while on a particular drug would be retained if on that drug again.
State-dependence is something of a misnomer, since there is AFAIK no drug in which recall is truly state-dependent. It is true however that information learned under one mental state is recalled a bit better under the same mental state; this includes not only cannabis but also caffeine and other stimulants, tobacco, alcohol, scopolomine, and other drugs. 'State-dependent' recall has also been demonstrated for non-drug-induced states. For instance, words learned while riding an exercise bike are better recalled while on the bike than at rest, and vice versa (Miles and Hardman, 1998).


Kelemen and Creeley, 2003. State-dependent memory effects using caffeine and placebo do not extend to metamemory. Gen Psychol. 130(1):70-86.

Miles and Hardman, 1998. State-dependent memory produced by aerobic exercise. Ergonomics 41(1):20-8.

Peters and McGee, 1982. Cigarette smoking and state-dependent memory. Psychopharmacology 76(3):232-5.


Quote:
Koy:
I was also wondering if anyone here had pierced through these stupid anti-pot propaganda ads of late (where the catch phrase is, "Marijuana. It's not as harmless as we all thought.")?
Given that marijuana was once thought to cause psychosis, blindness, homocidal rage, brain damage, genetic mutations, and impotence, I'd have to disagree.


Quote:
Theyeti:
To the best of my knowledge, there is no way to determine whether a person who has THC in their system was recently stoned, or was stoned a few weeks ago. I don't think that they can tell if an accident victim was stoned at the time of the accident, unless the person admits to it. Even if it can be determined, there needs to be controlled studies showing that marijuana is a causal factor in accidents, and not merely correlated.
Uggh! This brings up a bad memory for me. I used to work with a 40-something nurse. She was a great nurse, very compassionate. One day a patient crashed into her ankle with their wheelchair, fracturing it. She declined to have it x-rayed or seek medical care. That night, it began to hurt worse and worse. She took a prescription pain pill from a year-old prescription. The next day, she couldn't walk at all, and went to the hospital for x-ray. Sure enough, it was fractured. Blood or urinalysis (I dont know which) indicated the presence of the opioid pain pill, as well as THC metabolites. I don't recall how her situatuation turned out in the end, as we lost contact about this time, but she lost her job, was reported to the state board of nursing, and there was some kind of attempt (unsuccessful I think) to hold this woman financially liable for her own medical treatment. Of course, she never smoked pot on the job, never came to work high, and the opioids were from an old but legitimate prescription. This is the same thing that pisses me off about job-related urinalysis, particularly for THC metabolites -- you can't determine from their mere presence whether someone was smoking an hour ago or two weeks ago, yet employers and insurance companies often seem to make such assumptions.

Patrick
ps418 is offline  
Old 07-01-2003, 07:13 AM   #52
Veteran Member
 
Join Date: Mar 2001
Location: Louisville, KY, USA
Posts: 1,840
Default

There is a good review of research on the endogenous cannabinoids and cannabinoid receptors. Currently the 2 cannabinoid receptor subtypes, CB1 and CB2, and the endocannabinoids that activate them, are the focus of a lot of research, as targets for various therapeutic applications.
An Overview of the Endogenous Cannabinoid System

For instance, there was an article in Nature Medicine last year that demonstrated that when you inhibit the enzyme that normally breaks down anandamide (an endocannabinoid that activates CB1), this has an anti-anxiety effect in a rodent model. There is also research on cannabinoids looking at how they affect appetite and nausea -- which is good, since there are not many medicines that increase appetite, and many existing anti-nausea medicines are pretty toxic.

Yet other research and development--quite interesting in light of the topic of this thread -- seeks to exploit the neuroprotective qualities of cannabinoids: contrary to past reports that pot kills brain cells, it is now known that both THC and cannabidiol are potent protectors against glumate excito-toxicity, which causes massive brain cell death during ischaemic stroke (Hampson et al, 1998). This effect is not mediated by CB receptors, because the neuroprotective benefits are still seen when the cells have been pretreated with CB receptor antagonists. So, theoretically, a patient beginning a stroke or at high risk for one could be administered THC and/or cannabidiol, plus as CB receptor antagonist, and thus get a neuroprotective effect without actually getting any of the typical psychoactive effects of THC (which are mediated by the CB receptors). Actually, the study in PNAS suggests that cannabidiol may turn out to be much better than anything currently used for this purpose, such as butylhydroxytoluene (BHT), which has tumor-promoting qualities, or NMDA antagonists, which have their own side-effects. Cannnabidiol, in contrast, is quite benign, and not toxic at high doses.

It would not surpise me in the least if in the near future you see a new class of pharms based on endocannabinoid system interactions, much as you se so many new drugs now based on serotonin and dopamine systems.


Hampson et al, 1998. Cannabidiol and D-9 tetrahydrocannabinol are neuroprotective antioxidants. PNAS 95, pp. 8268–8273.

Kathuria et al, 2003. Modulation of anxiety through blockade of anandamide hydrolysis. Nature Medicine 9, pp 76 - 81.

Patrick
ps418 is offline  
Old 07-01-2003, 07:18 AM   #53
Contributor
 
Join Date: Jun 2000
Location: Buggered if I know
Posts: 12,410
Smile

Once again I thank blind fate that I do not live in the USA.
Gurdur is offline  
Old 07-01-2003, 07:36 AM   #54
Contributor
 
Join Date: Feb 2002
Location: With 10,000 lakes who needs a coast?
Posts: 10,762
Default

Quote:
Originally posted by Gurdur
Once again I thank blind fate that I do not live in the USA.
I'm assuming you're referring to your laws on marijuana. What are the laws and enforcement like in Germany? Or are you speculating that new drugs based on cannabinoids will be delayed because of our American anti-pot hysteria?
Godless Dave is offline  
Old 07-01-2003, 07:52 AM   #55
Veteran Member
 
Join Date: Mar 2001
Location: Louisville, KY, USA
Posts: 1,840
Default

Regarding the possibility of an association of cannabis smoking with lung cancer, I learned the following interesting bits of information last night that may explain how cannabis smoke may be much less carcinogenic than tobacco smoke, even on a per-voume basis, despite their overall chemical simularity.

The first bit is that nicotine-- a major component of tobacco smoke that is not in cannabis smoke-- actually inhibits apotosis. This is significant, because tobacco smoke clearly has "genotoxic" properties. So, with tobacco but not cannabis, you get both an increase in mutations in airway epithelial cells, AND an inhibition of cell death, which dramatically increases the probability that some of these cells will incur a set of mutations leading to cancerous cell growth! From West et al (2003):


Quote:
Activation of Akt by nicotine or NNK occurred within minutes at concentrations achievable by smokers and depended upon alpha(3)-/alpha(4)-containing or alpha(7)-containing nicotinic acetylcholine receptors, respectively. Activated Akt increased phosphorylation of downstream substrates such as GSK-3, p70(S6K), 4EBP-1, and FKHR. Treatment with nicotine or NNK attenuated apoptosis caused by etoposide, ultraviolet irradiation, or hydrogen peroxide and partially induced a transformed phenotype manifest as loss of contact inhibition and loss of dependence on exogenous growth factors or adherence to ECM. In vivo, active Akt was detected in airway epithelial cells and lung tumors from NNK-treated A/J mice, and in human lung cancers derived from smokers. Redundant Akt activation by nicotine and NNK could contribute to tobacco-related carcinogenesis by regulating two processes critical for tumorigenesis, cell growth and apoptosis.
The second observation, even more interesting, is that, strange as it may seem, cannabinoids have actually been demonstrated to have tumor-supressor properties in vitro, on a variety of cancer types! For instance, Casanova et al (2003) demonstrated that CB1 and CB2 agonists inhibited growth of skin cancers in vitro:

Quote:
In cell culture experiments pharmacological activation of cannabinoid receptors induced the apoptotic death of tumorigenic epidermal cells, whereas the viability of nontransformed epidermal cells remained unaffected. Local administration of the mixed CB(1)/CB(2) agonist WIN-55,212-2 or the selective CB(2) agonist JWH-133 induced a considerable growth inhibition of malignant tumors generated by inoculation of epidermal tumor cells into nude mice. Cannabinoid-treated tumors showed an increased number of apoptotic cells. This was accompanied by impairment of tumor vascularization, as determined by altered blood vessel morphology and decreased expression of proangiogenic factors (VEGF, placental growth factor, and angiopoietin 2). Abrogation of EGF-R function was also observed in cannabinoid-treated tumors. These results support a new therapeutic approach for the treatment of skin tumors.
Another study by McKallip et al (2002) showed the same thing for both mouse and human lymphoblastic tumor cells in vitro, using both THC and other CB2 agonists.

Quote:
In the current study, we examined whether ligation of CB2 receptors would lead to induction of apoptosis in tumors of immune origin and whether CB2 agonist could be used to treat such cancers. Exposure of murine tumors EL-4, LSA, and P815 to delta-9-tetrahydrocannabinol (THC) in vitro led to a significant reduction in cell viability and an increase in apoptosis. Exposure of EL-4 tumor cells to the synthetic cannabinoid HU-210 and the endogenous cannabinoid anandamide led to significant induction of apoptosis, whereas exposure to WIN55212 was not effective. Treatment of EL-4 tumor-bearing mice with THC in vivo led to a significant reduction in tumor load, increase in tumor-cell apoptosis, and increase in survival of tumor-bearing mice. Examination of a number of human leukemia and lymphoma cell lines, including Jurkat, Molt-4, and Sup-T1, revealed that they expressed CB2 receptors but not CB1. These human tumor cells were also susceptible to apoptosis induced by THC, HU-210, anandamide, and the CB2-selective agonist JWH-015. This effect was mediated at least in part through the CB2 receptors because pretreatment with the CB2 antagonist SR144528 partially reversed the THC-induced apoptosis. Culture of primary acute lymphoblastic leukemia cells with THC in vitro reduced cell viability and induced apoptosis. Together, the current data demonstrate that CB2 cannabinoid receptors expressed on malignancies of the immune system may serve as potential targets for the induction of apoptosis. Also, because CB2 agonists lack psychotropic effects, they may serve as novel anticancer agents to selectively target and kill tumors of immune origin.
Melck et al (2000) showed that the endogenous cannabinoids anandamide and 2-arachidonoylglycerol inhibit growth in vitro of both human breast cancer cells and prostate cancer cells. This affect is mediated by the CB1 receptor, as demonstrated by the use of a CB1 antagonist. The authors did not use THC, but given that THC is known to be a CB1 agonist, it may well have those properties as well.

Quote:
Here we report that 1) anandamide and 2-AG inhibit the nerve growth factor (NGF)-induced proliferation of HBCCs through suppression of the levels of NGF Trk receptors; 2) inhibition of PRLr levels results in inhibition of the proliferation of other PRL-responsive cells, the prostate cancer DU-145 cell line; and 3) CB1-like cannabinoid receptors are expressed in HBCCs and DU-145 cells and mediate the inhibition of cell proliferation and Trk/PRLr expression. Beta-NGF-induced HBCC proliferation was potently inhibited (IC50 = 50-600 nM) by the synthetic cannabinoid HU-210, 2-AG, anandamide, and its metabolically stable analogs, but not by the anandamide congener, palmitoylethanolamide, or the selective agonist of CB2 cannabinoid receptors, BML-190. The effect of anandamide was blocked by the CB1 receptor antagonist, SR141716A, but not by the CB2 receptor antagonist, SR144528. Anandamide and HU-210 exerted a strong inhibition of the levels of NGF Trk receptors as detected by Western immunoblotting; this effect was reversed by SR141716A. When induced by exogenous PRL, the proliferation of prostate DU-145 cells was potently inhibited (IC50 = 100-300 nM) by anandamide, 2-AG, and HU-210. Anandamide also down-regulated the levels of PRLr in DU-145 cells. SR141716A attenuated these two effects of anandamide. HBCCs and DU-145 cells were shown to contain 1) transcripts for CB1 and, to a lesser extent, CB2 cannabinoid receptors, 2) specific binding sites for [3H]SR141716A that could be displaced by anandamide, and 3) a CB1 receptor-immunoreactive protein. These findings suggest that endogenous cannabinoids and CB1 receptor agonists are potential negative effectors of PRL- and NGF-induced biological responses, at least in some cancer cells.
Refs

Casanova et al, 2003. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest. 111:43-50.

McKallip et al, 2002. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 100:627-634.

Melck et al, 2000. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 141:118-126.

West et al, 2003. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest. 111(1):81-90.

Patrick
ps418 is offline  
Old 07-01-2003, 08:55 AM   #56
Senior Member
 
Join Date: Aug 2002
Location: sugar factory
Posts: 873
Default rrraaaggh!

I'm going to look like a total moron but, with all due respect to mr scientist (ps418) how the hell do you expect me or dozens of other posters to work out where you're at. Talk about assuming knowledge on the readers behalf!

Quote:
Anandamide and HU-210 exerted a strong inhibition of the levels of NGF Trk receptors as detected by Western immunoblotting; this effect was reversed by SR141716A. When induced by exogenous PRL, the proliferation of prostate DU-145 cells was potently inhibited (IC50 = 100-300 nM) by anandamide, 2-AG, and HU-210.


no fair. Call me mr thicko but Western Immunoblotting is about as familiar to lil' ol' me as dog biscuits are to sea urchins. Please, please please, cater for the wider audience and help the laypeople to understand, or perhaps Its time to spend ten grand on a phD.

!QUESTION TIME!>>> dear ps418, I would like to know why it is that my nerves feel as though they're on fire after ingesting lots of hashish? It feels as though all the gates in my brain are open and if I don't relax, I'll pass out. Its really quite scary?????
sweep is offline  
Old 07-01-2003, 09:40 AM   #57
Veteran Member
 
Join Date: Mar 2001
Location: Louisville, KY, USA
Posts: 1,840
Default Re: rrraaaggh!

Quote:
Originally posted by sweep
I'm going to look like a total moron but, with all due respect to mr scientist (ps418) how the hell do you expect me or dozens of other posters to work out where you're at. Talk about assuming knowledge on the readers behalf!
The abstracts are included for those want to read them, but I always include a brief synopsis that can be understood by anyone with a basic understanding of neurology and pharmacology: receptors, agonists/antagonists, and so on. If you'd like clarification on something, feel free to ask. But I won't apologize for including detail.


Quote:
!QUESTION TIME!>>> dear ps418, I would like to know why it is that my nerves feel as though they're on fire after ingesting lots of hashish? It feels as though all the gates in my brain are open and if I don't relax, I'll pass out. Its really quite scary?????
Given the frequency with which you describe adverse reactions, I hope that you will consider ceasing or at least reducing your use of cannabis, particularly if you are "ingesting lots of hashish" as you say. As to your question, I'm not sure what the answer is. Among other possible factors, eating cannabis results in the production of psychoactive metabolites that are not present in the same amounts with smoked cannabis. The prime example is 11-hydroxy-THC, the blood level of which is much higher with oral cannabis than with smoked cannabis.

Patrick
ps418 is offline  
Old 07-01-2003, 11:51 AM   #58
Veteran Member
 
Join Date: Mar 2001
Location: Louisville, KY, USA
Posts: 1,840
Default

Quote:
Originally posted by Gurdur
Back to the spinal cord:
Anyone here want a trivia question ?
Take a guess at how long the longest neuron cell is in the human body ?
I'm assuming that this would be a neuron running to my feet along the spinal cord. Assuming that there are axons that reach all the way from my brain to my toes with no synapses, I'd say 6 feet in the longest nerve in my body. If there are synapses along the way, then I have no idea.

Patrick
ps418 is offline  
Old 07-01-2003, 11:53 AM   #59
Veteran Member
 
Join Date: Sep 2000
Location: Yes, I have dyslexia. Sue me.
Posts: 6,508
Thumbs up

Thanks everyone for all the info!

Does anyone know if "state-dependant" learning was factored in (or factored out) of any of the studies done on memory in regard to pot?

And another "final" question ( ): I've heard it told that THC triggers dormant THC (i.e., that regular users have "stored" THC or "residual" THC from past uses and when that user fires up, they don't need too much--one or two hits--to trigger the THC that is already in their systems).

True or false (old stoner's tale)?

Fascinating stuff, by the way!
Koyaanisqatsi is offline  
Old 07-01-2003, 12:18 PM   #60
Veteran Member
 
Join Date: Mar 2001
Location: Louisville, KY, USA
Posts: 1,840
Default

Quote:
Originally posted by Koyaanisqatsi
And another "final" question ( ): I've heard it told that THC triggers dormant THC (i.e., that regular users have "stored" THC or "residual" THC from past uses and when that user fires up, they don't need too much--one or two hits--to trigger the THC that is already in their systems).

True or false (old stoner's tale)?
I'm pretty certain that is a myth. THC is metabolized pretty quickly (the blood THC level drops to well-below psychoactive range within a couple of hours), and I don't see how it could be stored in any kind of dormant or reusable state. After all, if you take a chunk of cannabis that is already cured and let it sit out for a few days, it will lose most of its potency due to oxidation. I don't see either how THC could be stored without being broken down, or how it could be remobilized by taking in more THC. If there were such an effect, it should be easy to demonstrate in mice. You could give one group of mice regular, controlled doses, then stop the doses, then give them another, test dose. You could then compare the blood THC levels for the former-stoner mice to the never-stoned control mice, and see if the stoner-mice achieve higher blood THC levels.


Patrick
ps418 is offline  
 

Thread Tools Search this Thread
Search this Thread:

Advanced Search

Forum Jump


All times are GMT -8. The time now is 07:33 PM.

Top

This custom BB emulates vBulletin® Version 3.8.2
Copyright ©2000 - 2015, Jelsoft Enterprises Ltd.